Based on our previous success in driving human prostate cancer cells to the skeleton of host animals by overexpressing RANKL in these cells, we hypothesized that KRT13-overexpressing LNCaP cells must express similar markers associated with cell-survival-, EMT-, stem cell-, neuroendocrine cell-, developmental-, and osteomimicry-associated genes [22]. This evidence concerns the gene KRT13 and prostate cancer.